南美洲和中美洲结直肠癌市场预测至 2028 年 – COVID-19 影响和区域分析 – 按模式（诊断类型、治疗类型和影像类型）和最终用户（医院和诊断与研究实验室） A
No. of Pages: 152 | Report Code: BMIRE00026291 | Category: Life Sciences
No. of Pages: 152 | Report Code: BMIRE00026291 | Category: Life Sciences
南和南的结直肠癌市场中美洲预计将从2022年的6.817亿美元增长到2028年的8.145亿美元；预计 2022 年至 2028 年复合年增长率为 2.2%。
中国结直肠癌市场由于巴西结直肠癌发病率上升以及对结肠镜检查的需求增加，预计该地区的人口增长。由于预防癌症发生的技术不断进步，阿根廷的市场也有所增长。
其他国家南&中美洲结直肠癌市场分为智利、秘鲁、厄瓜多尔等国家。根据 GLOBOCAN 2020 数据，智利大约有 6,219 例结直肠癌新发病例，占男女所有新结直肠癌病例的 11.5%；秘鲁各年龄段新诊断结直肠癌病例约 4,636 例。
此外，大多数拉丁美洲国家缺乏足够的系统性筛查或预防计划。对50岁以上人群进行全面筛查是减少结直肠癌的一种经济有效的方法。几个南&中美洲国家制定了结直肠癌早期检测、管理和随访的国家指南。此外，乌拉圭已实施结直肠癌筛查计划，而智利、古巴和厄瓜多尔已启动试点研究。
随着新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动南部和南部地区的发展。中美洲结直肠癌市场在预测期内复合年增长率可观。
南美洲和南美洲中美洲结直肠癌市场收入及预测至 2028 年（百万美元）
南和北中美洲结直肠癌市场细分
南部和中部地区中美洲结直肠癌市场分为模式、最终用户和国家。根据模式，全球结直肠癌市场分为诊断类型、治疗类型和影像类型。 2022年，诊断类细分市场占据最大的市场份额，预计在预测期内复合年增长率最高。根据最终用户，全球结直肠癌市场分为医院和诊断与治疗。研究实验室。 2022年，医院细分市场将占据更大的市场份额。基于国家、南部和地区中美洲结直肠癌市场分为巴西、阿根廷和南美其他地区。中美洲。南部和南部的其他地区2022 年，中美洲占据最大市场份额。
雅培、安进公司、布鲁克公司、临床基因组技术有限公司、EDP Biotech Corporation、Epigenomics AG、F. Hoffmann-La Roche AG、Quest Diagnostics 和 VolitionRx Limited 是在南部和南部地区运营的领先公司之一。中美洲结直肠癌市场。
Strategic insights for South & Central America Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 681.70 Million |
| Market Size by 2028 | US$ 814.50 Million |
| Global CAGR (2022 - 2028) | 2.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 方式
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South & Central America Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Colorectal Cancer Market is valued at US$ 681.70 Million in 2022, it is projected to reach US$ 814.50 Million by 2028.
As per our report South & Central America Colorectal Cancer Market, the market size is valued at US$ 681.70 Million in 2022, projecting it to reach US$ 814.50 Million by 2028. This translates to a CAGR of approximately 2.2% during the forecast period.
The South & Central America Colorectal Cancer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Colorectal Cancer Market report:
The South & Central America Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Colorectal Cancer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Colorectal Cancer Market
